bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

hooksAmpRedirectArticle

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

paywallTypes

createdDate

publishedDate

urlAlias

moreOnThisArticles

sponsorType

commentCount

authorLocations

authors

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

articleSpeeches

socialHeadline

headline

images

flag

firstTopic

glossary

flattenTypeIds

image

relatedLinks

relatedNewsletters

__typename

sponsor

pdfFiles

seriesReverseOrder

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

readingTime

customTimezone

liveContents

SCMP Reporter

Fund management firm Value Partners has clarified that it does not hold stock in Far East Pharmaceutical Technology and has not conducted any trade in the stock in recent weeks. A report yesterday on Page A1 incorrectly said that Value Partners sold shares in the firm on Thursday.



Hong Kong taps Value Partners, 9 others to manage US$385 million residency scheme fund

Wave of Hong Kong openings by Western investment firms continues with Adams Street

JD.com’s property unit joins 2 firms in a US$1 billion Singapore Reit, sources say

Efforts needed to combat view ‘Hong Kong equals mainland China’: business leaders

Value Partners

Corrections & clarifications